1.
Service Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1.
Markets Covered
1.2.2.
Years Considered for Study
1.2.3.
Key Market Segmentations
2.
Research Methodology
2.1.
Objective of the Study
2.2.
Baseline Methodology
2.3.
Key Industry Partners
2.4.
Major Association and Secondary Sources
2.5.
Forecasting Methodology
2.6.
Data Triangulation & Validation
2.7. Assumptions and
Limitations
3.
Executive Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market
Drivers, Challenges, Trends
4.
Voice of Customer
4.1.
Considerations for Cold Storage in Cell & Gene Therapy Logistics
4.2.
Commonly Used Cryopreservation Techniques
4.3.
Demand, By Component
4.4.
Demand, By Services Offered
4.5.
Brand Awareness
5.
Impact of COVID-19 on United Kingdom Cell & Gene
Therapy Cold Chain Logistics Market
6. United Kingdom Cell
& Gene Therapy Market Overview
7. United Kingdom Cell
& Gene Therapy Cold Chain Logistics Market Outlook
7.1.
Market Size & Forecast
7.1.1.
By Value
7.2.
Market Share & Forecast
7.2.1.
By Component (Cryogenic Shippers, Cryogenic Storage
Freezers, Ultra Low Freezers, Cold Chain Management Systems, Shipment and
Storage Medium, Cryogenic Packout Kits Others {Shipment Containers, Reusable
Boxes, etc.})
7.2.2.
By Services Offered (Transportation, Storage, Packaging)
7.2.3.
By Mode of Transportation (Air, Ground, Water)
7.2.4.
By Holding Temperature Range (Cryogenic, Refrigerated,
Ambient, Others {Deep Freezers, Dry Ice, etc.}))
7.2.5.
By End User (Pharmaceutical & Biotechnology
Companies, Academic & Research Institutes, Others)
7.2.6. By
Region
7.2.7. By
Company (2022)
7.3.
Market Map
7.3.1.
By Component
7.3.2.
By Services Offered
7.3.3.
By Mode of Transportation
7.3.4.
By Holding Temperature Range
7.3.5.
By End User
7.3.6.
By Region
8. London Cell &
Gene Therapy Cold Chain Logistics Market Outlook
8.1.
Market Size & Forecast
8.1.1.
By Value
8.2.
Market Share & Forecast
8.2.1.
By Component
8.2.2.
By Services Offered
8.2.3.
By Mode of Transportation
8.2.4.
By Holding Temperature Range
8.2.5.
By End User
9. Southeast United
Kingdom Cell & Gene Therapy Cold Chain Logistics Market Outlook
9.1.
Market Size & Forecast
9.1.1.
By Value
9.2.
Market Share & Forecast
9.2.1.
By Component
9.2.2.
By Services Offered
9.2.3.
By Mode of Transportation
9.2.4.
By Holding Temperature Range
9.2.5.
By End User
10. East Anglia United
Kingdom Cell & Gene Therapy Cold Chain Logistics Market Outlook
10.1.
Market Size & Forecast
10.1.1.
By Value
10.2.
Market Share & Forecast
10.2.1.
By Component
10.2.2.
By Services Offered
10.2.3.
By Mode of Transportation
10.2.4.
By Holding Temperature Range
10.2.5.
By End User
11. Scotland Cell &
Gene Therapy Cold Chain Logistics Market Outlook
11.1.
Market Size & Forecast
11.1.1.
By Value
11.2.
Market Share & Forecast
11.2.1.
By Component
11.2.2.
By Services Offered
11.2.3.
By Mode of Transportation
11.2.4.
By Holding Temperature Range
11.2.5.
By End User
12. Southwest United
Kingdom Cell & Gene Therapy Cold Chain Logistics Market Outlook
12.1.
Market Size & Forecast
12.1.1.
By Value
12.2.
Market Share & Forecast
12.2.1.
By Component
12.2.2.
By Services Offered
12.2.3.
By Mode of Transportation
12.2.4.
By Holding Temperature Range
12.2.5.
By End User
13. East Midlands Cell
& Gene Therapy Cold Chain Logistics Market Outlook
13.1.
Market Size & Forecast
13.1.1.
By Value
13.2.
Market Share & Forecast
13.2.1.
By Component
13.2.2.
By Services Offered
13.2.3.
By Mode of Transportation
13.2.4.
By Holding Temperature Range
13.2.5.
By End User
14. Yorkshire &
Humberside Cell & Gene Therapy Cold Chain Logistics Market Outlook
14.1.
Market Size & Forecast
14.1.1.
By Value
14.2.
Market Share & Forecast
14.2.1.
By Component
14.2.2.
By Services Offered
14.2.3.
By Mode of Transportation
14.2.4.
By Holding Temperature Range
14.2.5.
By End User
15.
Market Dynamics
15.1.
Drivers
15.2.
Challenges
16.
Market Trends & Developments
16.1.
Product Launches
16.2.
Mergers & Acquisitions
16.3.
Recent Developments
17.
United Kingdom Cell & Gene Therapy Cold Chain
Logistics Market: SWOT Analysis
18.
Porter’s Five Forces Analysis
18.1.
Competition in the Industry
18.2.
Potential of New Entrants
18.3.
Power of Suppliers
18.4.
Power of Customers
18.5.
Threat of Substitute Products
19.
PESTLE Analysis
20.
Policy & Regulatory Landscape
21.
United Kingdom Economic Profile
22.
Competitive Landscape
22.1.
Business Overview
22.2.
Company Snapshot
22.3.
Products & Services
22.4.
Financials (In case of listed companies)
22.5.
Recent Developments
22.6.
SWOT Analysis
22.6.1.
Atelerix Ltd.
22.6.2.
Life Science Group
Ltd (LSG)
22.6.3.
Arvato Group
22.6.4.
DGP Intelius Ltd.
22.6.5.
QuickSTAT (A Kuehne
+ Nagel Company)
22.6.6.
BIOCAIR
22.6.7.
TrakCel
22.6.8.
Cryoport UK Limited
22.6.9.
Patheon UK Limited
(Thermo Fischer Scientific UK)
22.6.10.
Catalent UK
23. Strategic Recommendations
24. About Us & Disclaimer